Derek T Chalmers is President & CEO of Cara Therapeutics, Inc.. Currently has a direct ownership of 991,405 shares of CARA, which is worth approximately $257,765. The most recent transaction as insider was on Sep 07, 2021, when has been sold 20,000 shares (Common Stock) at a price of $15.47 per share, resulting in proceeds of $309,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 991K
0% 3M change
0% 12M change
Total Value Held $257,765

DEREK T CHALMERS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 07 2021
SELL
Open market or private sale
$309,400 $15.47 p/Share
20,000 Reduced 1.98%
991,405 Common Stock
Aug 30 2021
SELL
Open market or private sale
$119,848 $14.2 p/Share
8,440 Reduced 0.83%
1,011,405 Common Stock
Aug 24 2021
BUY
Grant, award, or other acquisition
-
17,334 Added 1.67%
1,019,845 Common Stock
Mar 30 2021
BUY
Grant, award, or other acquisition
-
52,000 Added 4.93%
1,002,511 Common Stock
Mar 05 2021
SELL
Open market or private sale
$55,792 $17.98 p/Share
3,103 Reduced 0.33%
950,511 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 1.04%
953,614 Common Stock
Feb 25 2021
SELL
Open market or private sale
$226,722 $19.33 p/Share
11,729 Reduced 1.23%
943,614 Common Stock
Feb 23 2021
BUY
Grant, award, or other acquisition
-
18,750 Added 1.92%
955,343 Common Stock
Dec 30 2020
SELL
Open market or private sale
$92,993 $15.3 p/Share
6,078 Reduced 0.64%
936,593 Common Stock
Dec 28 2020
SELL
Open market or private sale
$80,000 $16.0 p/Share
5,000 Reduced 0.53%
942,671 Common Stock
Dec 23 2020
BUY
Grant, award, or other acquisition
-
18,750 Added 1.94%
947,671 Common Stock
Dec 16 2020
SELL
Open market or private sale
$74,750 $14.95 p/Share
5,000 Reduced 0.54%
928,921 Common Stock
Dec 10 2020
SELL
Open market or private sale
$114,675 $15.29 p/Share
7,500 Reduced 0.8%
933,921 Common Stock
Nov 17 2020
SELL
Open market or private sale
$188,784 $16.0 p/Share
11,799 Reduced 1.24%
941,421 Common Stock
DTC

Derek T Chalmers

President & CEO
Stamford, CT

Track Institutional and Insider Activities on CARA

Follow Cara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CARA shares.

Notify only if

Insider Trading

Get notified when an Cara Therapeutics, Inc. insider buys or sells CARA shares.

Notify only if

News

Receive news related to Cara Therapeutics, Inc.

Track Activities on CARA